Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wonnacott

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Psychopharmacology|September 2, 2008
Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine releaseDavide Quarta, Christopher G Naylor, Jacques Barik, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivityGunter Karig, Jonathan M Large, Christopher G V Sharples, et al.
Addiction Biology|April 19, 2018
Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine-conditioned place preference and associated changes in AMPA receptor bindingVictoria L Wright, Polymnia Georgiou, Alexis Bailey, et al.
Neuropharmacology|November 6, 2004
Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380Adrian J Mogg, Francis A Jones, Ian A Pullar, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatumAdrian J Mogg, Paul Whiteaker, J Michael McIntosh, et al.
Cellular and Molecular Neurobiology|December 10, 2002
The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilitiesClaudio Da Cunha, Miriam Elizabeth Mendes Angelucci, Newton S Canteras, et al.
Journal of Neurochemistry|December 22, 2006
Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cellsJane A Dickinson, Katharine E Hanrott, M H Selina Mok, et al.
The European Journal of Neuroscience|March 4, 2008
Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesionsKatharine Hanrott, Tracey K Murray, Zeina Orfali, et al.
Journal of Molecular Neuroscience : MN|December 29, 2006
Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytesIan W Jones, Adam Westmacott, Elcie Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2008
Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptorsNeal Innocent, Phil D Livingstone, Arik Hone, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Psychopharmacology|September 2, 2008
Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine releaseDavide Quarta, Christopher G Naylor, Jacques Barik, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2003
Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivityGunter Karig, Jonathan M Large, Christopher G V Sharples, et al.
Addiction Biology|April 19, 2018
Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine-conditioned place preference and associated changes in AMPA receptor bindingVictoria L Wright, Polymnia Georgiou, Alexis Bailey, et al.
Neuropharmacology|November 6, 2004
Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380Adrian J Mogg, Francis A Jones, Ian A Pullar, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatumAdrian J Mogg, Paul Whiteaker, J Michael McIntosh, et al.
Cellular and Molecular Neurobiology|December 10, 2002
The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilitiesClaudio Da Cunha, Miriam Elizabeth Mendes Angelucci, Newton S Canteras, et al.
Journal of Neurochemistry|December 22, 2006
Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cellsJane A Dickinson, Katharine E Hanrott, M H Selina Mok, et al.
The European Journal of Neuroscience|March 4, 2008
Differential activation of PKC delta in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesionsKatharine Hanrott, Tracey K Murray, Zeina Orfali, et al.
Journal of Molecular Neuroscience : MN|December 29, 2006
Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytesIan W Jones, Adam Westmacott, Elcie Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2008
Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptorsNeal Innocent, Phil D Livingstone, Arik Hone, et al.
Pageof 7